University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Published Papers

Dr. Edward Machtinger

1. Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders. Read Paper

2. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. Read Paper

3. Atraumatic splenic rupture: an unusual manifestation of acute HIV infection.
Read Paper

4. Language, Literacy, and Communication Regarding Medication in an Anticoagulation Clinic: Are Pictures Better Than Words? Read Paper

5. Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication. Read Paper

6. A visual medication schedule to improve anticoagulation control: a randomized, controlled trial. Read Paper

7. Seven steps to better adherence: a practical approach to promoting adherence to antiretroviral therapy. Read Paper

8. Language, literacy, and communication regarding medication in an anticoagulation clinic: a comparison of verbal vs. visual assessment. Read Paper

9. The importance of establishing regimen concordance in preventing medication errors in anticoagulant care.
Read Paper

10. Health literacy and anticoagulation-related outcomes among patients taking warfarin. Read Paper

11. Etiology of pruritic papular eruption with HIV infection in Uganda. Read Paper

Dr. Deborah Cohan

1. Neonatal Mortality in HIV-Exposed Infants Born to Women Receiving Combination Antiretroviral Therapy in Rural Uganda. Read Paper

2. CDC should reverse its recommendation against semen washing-intrauterine insemination for HIV-serodifferent couples.
Read Paper

3. The Cost-Effectiveness of Repeat HIV Testing During Pregnancy in a Resource-Limited Setting. Read Paper

4. HIV and reproduction: fertility, contraception, and preconception issues and interventions. Read Paper

5. Antiretrovirals and safer conception for HIV-serodiscordant couples.
Read Paper

6. Trends in contraceptive use among women with human immunodeficiency virus.
Read Paper

7. Evaluating safer conception options for HIV-serodiscordant couples (HIV-infected female/HIV-uninfected male): a closer look at vaginal insemination. Read Paper

8. Preexposure prophylaxis for the prevention of HIV transmission to women.
Read Paper

9. Maternal nutritional status predicts adverse birth outcomes among HIV-infected rural Ugandan women receiving combination antiretroviral therapy.
Read Paper

10. Contraceptive use and barriers to access among newly arrested women.
Read Paper

11. Current knowledge and future research on infant feeding in the context of HIV: basic, clinical, behavioral, and programmatic perspectives. Read Paper

12. Interferon gamma release assay compared with the tuberculin skin test for latent tuberculosis detection in pregnancy. Read Paper

13. Group B Streptococcus colonization by HIV status in pregnant women: prevalence and risk factors. Read Paper

14. Safer conception options for HIV-serodiscordant couples. Read Paper

15. Perinatal depressive symptoms in HIV-infected versus HIV-uninfected women: a prospective study from preconception to postpartum. Read Paper

16. Relative time to pregnancy among HIV-infected and uninfected women in the Women’s Interagency HIV Study, 2002-2009. Read Paper

17. The human fetal immune response to hepatitis C virus exposure in utero. Read Paper

18. Mode of delivery and infant respiratory morbidity among infants born to HIV-1-infected women. Read Paper

19. Emergency contraception for newly arrested women: evidence for an unrecognized public health opportunity. Read Paper

20. Delivery options for prevention of perinatal HIV transmission. Read Paper

21. Criminalization, legalization or decriminalization of sex work: what female sex workers say in San Francisco, USA. Read Paper

22. Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda. Read Paper

23. Patient perspectives with abbreviated versus standard pre-test HIV counseling in the prenatal setting: a randomized-controlled, non-inferiority trial. Read Paper

24. Increased uptake of HIV testing with the integration of nurse-initiated HIV testing into routine prenatal care.
Read Paper

25. HIV testing attitudes and practices among clinicians in the era of updated Centers for Disease Control and Prevention recommendations. Read Paper

26. Assisted reproduction for couples affected by human immunodeficiency virus in California. Read Paper

27. Rapid human immunodeficiency virus testing on labor and delivery. Read Paper

28. Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India. Read Paper

29. Patient acceptance of and satisfaction with rapid HIV Testing in a Labor and Delivery Setting. Read Paper

30. Rapid HIV testing on labor and delivery: lessons from the field. Read Paper

31. Consultation needs in perinatal HIV care: experience of the National Perinatal HIV Consultation Service.
Read Paper

32. Rapid point-of-care HIV testing in pregnant women: a systematic review and meta-analysis. Read Paper

33. Editorial comment: within our reach–the end of perinatal HIV transmission. Read Paper

34. Cesarean delivery and perinatal HIV transmission: waiting for definitive data. Read Paper

35. Perinatal transmission of multidrug-resistant HIV-1 despite viral suppression on an enfuvirtide-based treatment regimen.
Read Paper

36. Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort.
Read Paper

37. Perinatal HIV: special considerations. Read Paper

38. Cesarean delivery and risk of herpes simplex virus infection. Read Paper

Jennifer Cocohoba, PharmD

1. Improved antiretroviral refill adherence in HIV-focused community pharmacies.
Read Paper

2. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. Read Paper

3. Pharmacist counseling in a cohort of women with HIV and women at risk for HIV.
Read Paper

4. Making sense of side effects. Read Paper

5. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Read Paper

6. Health care provider satisfaction with telephone consultations provided by pharmacists and physicians at the National HIV/AIDS Clinicians’ Consultation Center. Read Paper

7. A comparison of tenofovir-associated renal function changes in HIV-infected African Americans vs Caucasians. Read Paper

8. Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART. Read Paper

9. The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women. Read Paper

10. Hormonal contraception for HIV positive women.
Read Paper

11. The SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individuals. Read Paper

12. Raltegravir: the first HIV integrase inhibitor.
Read Paper

13. HIV postexposure prophylaxis availability in U.S. rural hospitals. Read Paper

14. Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives. Read Paper

15. Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women. Read Paper

16. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. Read Paper

17. Refusals by pharmacists to dispense emerging contraception: a critique.
Read Paper

18. Tipranavir: a protease inhibitor for HIV salvage therapy. Read Paper

19. Potential adverse effects and inferior efficacy in ARV treatment. Read Paper

20. Valganciclovir: an advance in cytomegalovirus therapeutics. Read Paper